Marking 20 years since Professor Shinya Yamanaka's groundbreaking iPS cell discovery, Japan advances toward world-first regulatory approval of regenerative medicine products in 2026. Explore the latest clinical trials for Parkinson's disease treatment and heart failure therapy, and discover how this Japanese innovation is revolutionizing global medicine.

Japanese startup Pormedtec targets 2027 for Japan's first pig-to-human organ transplant trials. With only 4% of 16,000 registered transplant candidates receiving organs annually, xenotransplantation offers hope. US trials show gene-edited pig kidneys functioning over 7 months in human patients. Will this breakthrough transform Japan's organ shortage crisis?